NCT06470451
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL treatment 3 not_yet_recruiting NCT04491825
Diagnostic Classifier for Cutaneous T-cell Lymphomas No drug interventions Not Available Not Available unknown_status NCT01579318
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma treatment 2 terminated NCT02580552
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL treatment 1 completed NCT04676087
Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides treatment 1 / 2 terminated NCT02811783
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL treatment 3 terminated NCT03398161
Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides No drug interventions treatment 2 recruiting NCT06421571
The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients No drug interventions Not Available Not Available recruiting NCT03695471
Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides treatment 2 active_not_recruiting NCT05538988
BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma treatment 1 / 2 not_yet_recruiting NCT00129415
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions No drug interventions treatment 1 / 2 terminated NCT00254332
Effect of Denileukin Diftitox on Immune System in CTCL Patients No drug interventions Not Available Not Available completed NCT00535470
An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides treatment 2 completed NCT02943642
Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides treatment 2 unknown_status NCT01578499
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) treatment 3 completed NCT02881749
Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides treatment 2 unknown_status NCT01134341
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma treatment 1 completed NCT04541017
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment treatment 1 / 2 active_not_recruiting NCT02542124
NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) treatment 2 unknown_status NCT01609816
Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma treatment 1 terminated NCT05138458
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL No drug interventions treatment 1 / 2 suspended NCT05680558
Photopheresis in Early-stage Mycosis Fungoides treatment 2 recruiting NCT00221039
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A treatment 4 completed NCT05904522
Histopathological Changes in Mycosis Fungoides No drug interventions diagnostic Not Available recruiting NCT04234048
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma treatment 1 recruiting NCT03380026
Mechlorethamine Induced Contact Dermatitis Avoidance Study supportive_care 2 completed NCT02848274
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome No drug interventions Not Available Not Available recruiting NCT00157274
Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome treatment 2 unknown_status NCT04185220
Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome treatment 1 completed NCT00038376
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies treatment 2 completed NCT05855460
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study No drug interventions Not Available Not Available recruiting NCT05357794
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides treatment 2 recruiting NCT04955340
A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat treatment 1 completed NCT01445340
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma treatment 1 terminated NCT02890368
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides treatment 1 terminated NCT00177268
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research No drug interventions Not Available Not Available recruiting NCT00611208
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) treatment 2 completed NCT05526638
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides No drug interventions diagnostic Not Available recruiting NCT00496743
Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides No drug interventions treatment Not Available terminated NCT00177190
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) No drug interventions Not Available Not Available completed NCT03789864
Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides No drug interventions device_feasibility Not Available terminated NCT00168064
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides treatment 2 completed NCT05205902
TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides No drug interventions other 3 not_yet_recruiting NCT05872854
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light treatment 2 recruiting NCT01556828
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing No drug interventions Not Available Not Available terminated NCT00226993
Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides. treatment 1 / 2 withdrawn NCT03267407
Vietnam Cryptococcal Retention in Care Study - Version 2.1 No drug interventions Not Available Not Available unknown_status NCT02341209
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma treatment 2 terminated NCT02652715
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma No drug interventions basic_science Not Available completed NCT01590732
Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma treatment 1 completed NCT05414500
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides treatment 1 recruiting NCT00091559
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) treatment 2 completed NCT02323659
Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas treatment 4 terminated NCT01396070
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level treatment 2 completed NCT00050999
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients treatment 4 completed NCT05838599
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides treatment 0 recruiting NCT04960618
Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome treatment 2 recruiting NCT03288818
Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides treatment 2 withdrawn NCT04256018
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome treatment 2 recruiting NCT00178841
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL treatment 2 completed NCT05978141
A Registry for People With T-cell Lymphoma No drug interventions Not Available Not Available recruiting NCT02883517
Cell-free Circulating DNA in Primary Cutaneous Lymphomas No drug interventions Not Available Not Available completed NCT05879458
Ritlecitinib in CTCL treatment 2 recruiting NCT03905135
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies treatment 1 completed NCT06508463
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma treatment 1 recruiting NCT02822586
TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome treatment 1 completed NCT03602157
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL treatment 1 recruiting NCT00185965
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas treatment 1 / 2 completed NCT01352520
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) treatment 2 active_not_recruiting NCT00047060
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome treatment 1 / 2 completed NCT02301494
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma treatment Not Available withdrawn NCT05944562
Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and Sézary Syndrome No drug interventions treatment 1 recruiting NCT05303480
Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides treatment Not Available completed NCT03587844
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients treatment 2 recruiting NCT00985140
Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides No drug interventions Not Available Not Available terminated NCT02953301
Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) treatment 2 completed NCT04118868
Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma. treatment 1 recruiting NCT04904146
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. No drug interventions Not Available Not Available recruiting NCT06207812
Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis No drug interventions Not Available Not Available recruiting NCT00051012
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients treatment 4 completed NCT00127881
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome treatment 3 terminated NCT06235281
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) treatment 0 recruiting NCT02296164
Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma Not Available Not Available completed NCT00368784
T Cell Repertoire Analysis of Immune Mediated Skin Diseases No drug interventions Not Available Not Available completed